ABC Health - WOND
Sheldon Cooper/SOPA Images/LightRocket via Getty Images(NEW YORK) -- In a move welcomed by advocates, a treatment for multi-drug resistant tuberculosis could soon become more accessible for millions of people worldwide. Although tuberculosis is uncommon in the U.S., it is the top infectious disease killer worldwide after COVID-19, claiming an estimated 1.6 million lives in 2021, according to the World Health Organization. A life-saving drug called bedaquiline, when used along with other medicat...
Source: wondradio.com